⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL17114599 | 0.89 | — | — | |
| SCHEMBL1373713 | 0.87 | — | — | |
| Piperidine SCHEMBL22556777 | 0.86 | TSHR (0.33) | — | |
| SCHEMBL9751986 | 0.84 | — | — | |
| SCHEMBL1433046 | 0.80 | — | — | |
| SCHEMBL2241122 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL12479156 | 0.78 | — | — | |
| SCHEMBL8132933 | 0.77 | ALDH1A1 (0.45) | — | |
| SCHEMBL6205702 | 0.71 | TP53 (0.36) | — | |
| SCHEMBL3717746 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3759113-B1 | 10-(DI(PHENYL)METHYL)-4-HYDROXY-8,9,9A,10-TETRAHYDRO-7H-PYRROLO[1',2':4,5]PYRAZINO[1,2-B]PYRIDAZINE-3,5-DIONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE ORTHOMYXOVIRUS REPLICATION FOR TREATING INFLUENZA | NOVARTIS AG (CH) | 2024-09-11 | — | — | EP | claimed |
| CN-117705184-A | Detection method for chemical components of anemone-resistant tung tree | 中国热带农业科学院热带作物品种资源研究所 | 2024-03-15 | — | — | CN | claimed |
| CN-102151282-A | Application of iridoid glycoside and derivatives thereof as plasmin inhibitor and medicine composites of plasmin inhibitor | ZHENGPING JIA | 2011-08-17 | — | — | CN | claimed |
| EP-1181017-A1 | METALLOPROTEASE INHIBITORS | Pfizer Limited (GB) | 2002-02-27 | — | — | EP | claimed |
| WO-2000074681-A1 | METALLOPROTEASE INHIBITORS | PFIZER LIMITED (GB) | 2000-12-14 | — | — | WO | claimed |
| CN-122070276-A | Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same | 人类生物科学股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260116921-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| CN-121779365-A | Synthesis method of 4-aminotetralin-2H-pyran-4-formic acid | 宁波人健化学制药有限公司 | 2026-04-03 | — | — | CN | disclosed |
| EP-4705289-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | Terran Biosciences Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4706671-A2 | CONJUGATED HEPCIDIN MIMETICS | Protagonist Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-3570864-B1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12552836-B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | PROTAGONIST THERAPEUTICS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| EP-0787127-B1 | 5-LIPOXYGENASE INHIBITORS | PFIZER (US) | 2001-01-03 | — | — | EP | disclosed |
| EP-0992510-A1 | N6 heterocyclic substituted adenosine derivatives | CV THERAPEUTICS, INC. (US) | 2000-04-12 | — | — | EP | disclosed |
| US-6022888-A | Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient | TSUMURA & CO. (JP) | 2000-02-08 | — | — | US | disclosed |
| EP-0920438-A2 | N6 HETEROCYCLIC SUBSTITUTED ADENOSINE DERIVATIVES | CV THERAPEUTICS, INC. (US) | 1999-06-09 | — | — | EP | disclosed |
| US-5789416-A | CARDIOVASCULAR AND NERVOUS SYSTEM DISORDERS | CV THERAPEUTICS (US) | 1998-08-04 | — | — | US | disclosed |
| WO-1998008855-A2 | N6 HETEROCYCLIC SUBSTITUTED ADENOSINE DERIVATIVES | CV THERAPEUTICS, INC. (US) | 1998-03-05 | — | — | WO | disclosed |
| EP-0787127-A1 | 5-LIPOXYGENASE INHIBITORS | PFIZER INC. (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996011911-A1 | 5-LIPOXYGENASE INHIBITORS | PFIZER INC. (US) | 1996-04-25 | — | — | WO | disclosed |